Means "Erinit" (tablets) describes the instruction as a
peripheral vasodilator. The medication has an effect mainly on the venous vessels, has an antianginal effect. The activity of the drug is caused by a decrease in pre- and afterload (decrease in vascular resistance). The mechanism of action is also based on the manifestation of a direct coronary expansion effect. In patients with coronary heart disease and angina pectoris, when taking the medicine, an increase in exercise tolerance (tolerance) is noted. There is also a decrease in pressure in the small circle. The drug “Erinit” contributes to the redirection of coronary blood flow to areas of reduced blood supply. Medication "Erinit" (indications for use - the main cardiovascular pathology), compared with the
tool "Nitroglycerin", is slower. However, the therapeutic efficacy of the latter is longer. During oral administration, a slow absorption from the digestive system is observed. The active substance is pentaertitrityl tetranitrate.
Means "Erinit". Indications for use
A medication is prescribed for patients with angina pectoris, ischemic heart disease. The medicine is recommended for the prevention of attacks in the post-infarction period, including. In complex therapy, a remedy is prescribed for heart failure.
Dosage regimen
When choosing a dose of Erinit medicine, indications for use, patient tolerance, age and severity of the pathology are determining factors. The reception scheme in this regard is set personally. Unless otherwise prescribed by the doctor, dosing is carried out according to the annotation. The medication is recommended for administration of 20 mg three to four times a day. In some cases, the dosage can be increased to 40 mg 4 r / day or drink 80 mg 2 r / day.
Side effects
Erinit, the indications for use of which are given above, can provoke dyspepsia, anxiety or a feeling of tiredness. Rarely, patients experience headache, orthostatic hypotension, or dizziness during therapy. Allergic skin reactions and excessive sweating are also considered complications when taking the medicine.
Contraindications
Not recommended for recently or acute myocardial infarction, severe arterial hypotension. No medication is prescribed for patients with increased intraocular and intracranial pressure, hypersensitivity. There are no direct contraindications to taking the drug in the prenatal period and with lactation. However, the appointment of pregnant and lactating patients is carried out by a specialist. Therapy is carried out under careful medical supervision. At the beginning of treatment with Erinit®, indications for use are not the only things to pay attention to. Ignoring information about restrictions on admission can lead to serious consequences.